The US Food and Drug Administration on Saturday approved a coronavirus diagnostic test that can be conducted entirely at the point-of-care and can deliver results in 45 minutes. The approval of such a diagnostics test developed by California-based Cephid would help in the fast identification of infected people and quickly start treating them and their quarantine. The test will begin shipping next week.from IndiaTV: Google News Feed https://ift.tt/2xhAAYS
comment 0 Comments
more_vert